Nicotinamide-N-methyltransferase is a promising metabolic drug target for primary and metastatic clear cell renal cell carcinoma.
Reustle A, Menig LS, Leuthold P, Hofmann U, Stühler V, Schmees C, Becker M, Haag M, Klumpp V, Winter S, Büttner FA, Rausch S, Hennenlotter J, Fend F, Scharpf M, Stenzl A, Bedke J, Schwab M, Schaeffeler E.
Reustle A, et al. Among authors: schwab m.
Clin Transl Med. 2022 Jun;12(6):e883. doi: 10.1002/ctm2.883.
Clin Transl Med. 2022.
PMID: 35678045
Free PMC article.